ASTX Key Stats
- Nasdaq stocks posting largest percentage decreases May 22
- Astex Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20... May 20
- Astex Pharmaceuticals' CEO Presents at UBS Global Healthcare Conference (Transcr... May 20
- ASTEX PHARMACEUTICALS, INC Financials May 17
- Astex Pharmaceuticals to Present at UBS Global Healthcare Conference GlobeNewswire May 14
- Short Interest Moves 16% Higher For ASTX May 10
- ASTEX PHARMACEUTICALS, INC Files SEC form 10-Q, Quarterly Report May 10
- Astex Pharmaceuticals (ASTX) Hits Session Lows on Heavy Volume Street Insider May 8
- 3 Horrendous Health-Care Stocks This Week Fool May 4
- Astex Pharma (ASTX) Decline Tied to 'Re-risking' Street Insider May 1
ASTX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Astex Pharmaceuticals is up 218.0% over the last year vs S&P 500 Total Return up 28.33%, AcelRx Pharmaceuticals up 113.8%, and GlaxoSmithKline up 24.96%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for ASTX
Pro Report PDF for ASTX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download ASTX Pro Report PDF
Pro Strategies Featuring ASTX
Did Astex Pharmaceuticals make it into our Pro Portfolio Strategies?